Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1981 1
1982 2
1986 1
1994 1
2001 2
2002 4
2004 5
2005 5
2006 4
2007 3
2008 5
2009 8
2010 7
2011 21
2012 12
2013 13
2014 8
2015 7
2016 7
2017 7
2018 7
2019 6
2020 4
2021 7
2022 11
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: tamaru s. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: tamaru s. Haematologica. 2020 Sep 1;105(9):2308-2315. doi: 10.3324/haematol.2019.231076. Haematologica. 2020. PMID: 33054055 Free PMC article. Clinical Trial.
Endometrial microRNAs and their aberrant expression patterns.
Tamaru S, Kajihara T, Mizuno Y, Mizuno Y, Tochigi H, Ishihara O. Tamaru S, et al. Med Mol Morphol. 2020 Sep;53(3):131-140. doi: 10.1007/s00795-020-00252-8. Epub 2020 Apr 29. Med Mol Morphol. 2020. PMID: 32350620 Review.
Lansoprazole Ameliorates Isoniazid-Induced Liver Injury.
Wakai E, Shiromizu T, Otaki S, Koiwa J, Tamaru S, Nishimura Y. Wakai E, et al. Among authors: tamaru s. Pharmaceuticals (Basel). 2024 Jan 8;17(1):82. doi: 10.3390/ph17010082. Pharmaceuticals (Basel). 2024. PMID: 38256915 Free PMC article.
COVID-19 mRNA vaccination status and concerns among pregnant women in Japan: a multicenter questionnaire survey.
Takahashi K, Samura O, Hasegawa A, Okubo H, Morimoto K, Horiya M, Okamoto A, Ochiai D, Tanaka M, Sekiguchi M, Miyasaka N, Suzuki Y, Tabata T, Hayata E, Nakata M, Suzuki T, Nishi H, Toda Y, Tanigaki S, Furuya N, Hasegawa J, Tamaru S, Kamei Y, Sayama S, Nagamatsu T, Takahashi YO, Kitagawa M, Arakaki T, Sekizawa A. Takahashi K, et al. Among authors: tamaru s. BMC Pregnancy Childbirth. 2023 May 9;23(1):332. doi: 10.1186/s12884-023-05669-4. BMC Pregnancy Childbirth. 2023. PMID: 37161480 Free PMC article.
Diagnosis and molecular basis of mitochondrial respiratory chain disorders: exome sequencing for disease gene identification.
Ohtake A, Murayama K, Mori M, Harashima H, Yamazaki T, Tamaru S, Yamashita Y, Kishita Y, Nakachi Y, Kohda M, Tokuzawa Y, Mizuno Y, Moriyama Y, Kato H, Okazaki Y. Ohtake A, et al. Among authors: tamaru s. Biochim Biophys Acta. 2014 Apr;1840(4):1355-9. doi: 10.1016/j.bbagen.2014.01.025. Epub 2014 Jan 24. Biochim Biophys Acta. 2014. PMID: 24462578 Free article. Review.
154 results